SARA BALLARD: Open Payments
NPI 1730877713 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 43 payments from 11 companies in 2025. Trend: 2023 $441 · 2024 $1,350 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $161 |
| AstraZeneca Pharmaceuticals LP | 9 | $139 |
| Lilly USA, LLC | 7 | $133 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| Dexcom, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: JARDIANCE, VRAYLAR, AIRSUPRA, UBRELVY, MOUNJARO, TRELEGY ELLIPTA, BREZTRI, LEQVIO.
Industry payments across KY — which companies pay providers there.
